0001209191-24-003782.txt : 20240222
0001209191-24-003782.hdr.sgml : 20240222
20240222141948
ACCESSION NUMBER: 0001209191-24-003782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byam Rebecca
CENTRAL INDEX KEY: 0001866256
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40591
FILM NUMBER: 24664152
MAIL ADDRESS:
STREET 1: C/O HCW BIOLOGICS, INC.
STREET 2: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCW Biologics Inc.
CENTRAL INDEX KEY: 0001828673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825024477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 954-842-2024
MAIL ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-20
0
0001828673
HCW Biologics Inc.
HCWB
0001866256
Byam Rebecca
C/O HCW BIOLOGICS INC
2929 N. COMMERCE PARKWAY
MIRAMAR
FL
33025
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-02-20
4
A
0
760714
1.40
A
1381909
D
The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
2024-02-22